ROIV logo

Roivant Sciences (ROIV) EBIT

Annual EBIT

$4.29 B
+$5.49 B+458.29%

31 March 2024

ROIV EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$341.71 M
-$425.26 M-509.02%

30 September 2024

ROIV Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

$4.67 B
-$141.77 M-2.95%

30 September 2024

ROIV TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ROIV EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+458.3%-70.9%+539.5%
3 y3 years+578.7%-52.8%+592.7%
5 y5 years---

ROIV EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+458.3%-106.7%+8.5%-3.0%+454.4%
5 y5 yearsat high+458.3%-106.7%+8.5%-3.0%+454.4%
alltimeall timeat high+458.3%-106.7%+8.5%-3.0%+454.4%

Roivant Sciences EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$341.71 M(-509.0%)
$4.67 B(-2.9%)
June 2024
-
$83.54 M(-145.3%)
$4.81 B(+9.1%)
Mar 2024
$4.29 B(-458.3%)
-$184.28 M(-103.6%)
$4.41 B(-0.3%)
Dec 2023
-
$5.11 B(-2654.6%)
$4.42 B(-516.4%)
Sept 2023
-
-$199.94 M(-37.0%)
-$1.06 B(-9.0%)
June 2023
-
-$317.18 M(+85.9%)
-$1.17 B(-2.5%)
Mar 2023
-$1.20 B
-$170.64 M(-54.3%)
-$1.20 B(-9.1%)
Dec 2022
-
-$373.63 M(+22.3%)
-$1.32 B(+5.5%)
Sept 2022
-
-$305.42 M(-12.0%)
-$1.25 B(+7.0%)
DateAnnualQuarterlyTTM
June 2022
-
-$347.17 M(+19.7%)
-$1.17 B(+27.1%)
Mar 2022
-$916.71 M(+2.3%)
-$290.00 M(-4.8%)
-$916.71 M(-7.6%)
Dec 2021
-
-$304.55 M(+36.1%)
-$992.38 M(+4.8%)
Sept 2021
-
-$223.69 M(+127.2%)
-$946.90 M(+7.6%)
June 2021
-
-$98.47 M(-73.1%)
-$879.76 M(-1.8%)
Mar 2021
-$895.74 M
-$365.67 M(+41.1%)
-$895.74 M(+69.0%)
Dec 2020
-
-$259.07 M(+65.5%)
-$530.06 M(+95.6%)
Sept 2020
-
-$156.54 M(+36.8%)
-$270.99 M(+136.8%)
June 2020
-
-$114.45 M
-$114.45 M

FAQ

  • What is Roivant Sciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Roivant Sciences?
  • What is Roivant Sciences annual EBIT year-on-year change?
  • What is Roivant Sciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Roivant Sciences?
  • What is Roivant Sciences quarterly EBIT year-on-year change?
  • What is Roivant Sciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Roivant Sciences?
  • What is Roivant Sciences TTM EBIT year-on-year change?

What is Roivant Sciences annual earnings before interest & taxes?

The current annual EBIT of ROIV is $4.29 B

What is the all time high annual EBIT for Roivant Sciences?

Roivant Sciences all-time high annual earnings before interest & taxes is $4.31 B

What is Roivant Sciences annual EBIT year-on-year change?

Over the past year, ROIV annual earnings before interest & taxes has changed by +$5.49 B (+458.29%)

What is Roivant Sciences quarterly earnings before interest & taxes?

The current quarterly EBIT of ROIV is -$341.71 M

What is the all time high quarterly EBIT for Roivant Sciences?

Roivant Sciences all-time high quarterly earnings before interest & taxes is $5.11 B

What is Roivant Sciences quarterly EBIT year-on-year change?

Over the past year, ROIV quarterly earnings before interest & taxes has changed by -$141.77 M (-70.91%)

What is Roivant Sciences TTM earnings before interest & taxes?

The current TTM EBIT of ROIV is $4.67 B

What is the all time high TTM EBIT for Roivant Sciences?

Roivant Sciences all-time high TTM earnings before interest & taxes is $4.81 B

What is Roivant Sciences TTM EBIT year-on-year change?

Over the past year, ROIV TTM earnings before interest & taxes has changed by +$5.73 B (+539.55%)